Amar, Ali
Majmundar, Amar J.
Ullah, Ihsan
Afzal, Ayesha
Braun, Daniela A.
Shril, Shirlee
Daga, Ankana
Jobst-Schwan, Tilman
Ahmad, Mumtaz
Sayer, John A.
Gee, Heon Yung
Halbritter, Jan
Knöpfel, Thomas
Hernando, Nati
Werner, Andreas
Wagner, Carsten
Khaliq, Shagufta
Hildebrandt, Friedhelm http://orcid.org/0000-0002-4167-8411
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK076683)
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007726)
Harvard Stem Cell Institute (Post-doctoral Fellowship Grant)
American Society of Nephrology and Polycystic Kidney Disease Foundation (Jared J. Grantham Research Fellowship)
National Research Foundation of Korea (2015R1D1A1A01056685)
Deutsche Forschungsgemeinschaft (Jo 1324/1-1)
Higher Education Commission, Pakistan through National Research Program for Universities (HEC1987)
International Research Support Initiative Program
Kidney Research UK and the Northern Counties Kidney Research Fund
Article History
Received: 7 December 2018
Accepted: 7 February 2019
First Online: 18 February 2019
Compliance with ethical standards
:
: F.H. is a co-founder of Goldfinch Biopharma Inc. The other authors declare that they have no competing financial interests. No part of this manuscript has been previously published.